UK Markets close in 3 hrs 57 mins

Subsea 7 S.A. (SUBCY)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
9.01-0.28 (-3.01%)
At close: 03:49PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close9.29
Open9.01
Bid0.00 x 0
Ask0.00 x 0
Day's range8.94 - 9.01
52-week range6.47 - 10.90
Volume8,322
Avg. volume23,761
Market cap2.699B
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yield0.11 (1.26%)
Ex-dividend date28 Apr 2022
1y target estN/A
  • Globe Newswire

    Subsea 7 awarded contract offshore Norway

    Luxembourg – 11 August 2022 - Subsea 7 S.A. (Oslo Børs: SUBC, ADR: SUBCY) today announced the award of a sizeable1 contract by Aker BP for the Trell & Trine field development, located in the Alvheim area of the North Sea. The project involves a subsea tie-back of approximately 21 kilometers to the Alvheim FPSO, via the existing East Kameleon subsea manifold. The contract scope includes engineering, procurement, construction and installation (EPCI) of the pipelines, spools, protection covers and

  • Globe Newswire

    Subsea 7 share repurchases

    Luxembourg – 1 August 2022 - Subsea 7 S.A. (Oslo Børs: SUBC, ADR: SUBCY) today announced transactions made in accordance with its share repurchase programme during the week commencing 25 July 2022. Date on which the share repurchase programme was announced: 25 July 2019, with a two-year extension announced on 16 April 2021. The duration of the share repurchase programme: until 14 April 2023. In the period from 25 July 2022 until 29 July 2022 Subsea 7 S.A. repurchased a total of 150,152 of its ow

  • Globe Newswire

    Subsea 7 S.A. Announces Second Quarter and Half Year 2022 Results (Amended)

    Amended to reflect an issue with the PDF attachment in the prior release Luxembourg – 28 July 2022 – Subsea 7 S.A. (the Group) (Oslo Børs: SUBC, ADR: SUBCY, ISIN: LU0075646355) announced today results for the second quarter and first half of 2022 which ended 30 June 2022. Second quarter highlights Adjusted EBITDA of $134 million, up 48% year-on-year, resulting in a margin of 11%Order intake of $2.1 billion, equating to a book-to-bill of 1.6 timesBacklog of $7.8 billion, of which 10% is in Renewa